SweetSpot
3 known investors
SweetSpot provides a remote diabetes monitoring and management platform that improves data accessibility for clinicians and supports patients using diabetes technology such as CGMs and insulin pumps. It serves diabetes care providers and patients in the digital health space.
Founders & leadership
.png)
.png)
.png)
.png)
Investors · 3
Missouri Technology CorporationSt. Louis
Cultivation Capitalreported · 3 sourcesSt. Louis · $100K – $3.5M
Also in the syndicate · 1
BioGenerator
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundSep 2025
Cultivation Capital (lead), BioGenerator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap
DexCom80 shared keywordsDexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver. Its products serve people managing diabetes as well as consumers tracking glucose for general health, diet, and exercise.
Diabetes73 shared keywordsA nonprofit organization that provides educational resources and information about prediabetes, including prevention strategies and lifestyle management for Americans at risk of developing type 2 diabetes.
Companies competing with SweetSpot for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does SweetSpot do?
- SweetSpot provides a remote diabetes monitoring and management platform that improves data accessibility for clinicians and supports patients using diabetes technology such as CGMs and insulin pumps. It serves diabetes care providers and patients in the digital health space.
- Who are SweetSpot's investors?
- SweetSpot's investors include Missouri Technology Corporation, Cultivation Capital.